Conversion Therapy for Advanced Hepatocellular Carcinoma Following Complete Response to Transarterial Radioembolization Combined with Atezolizumab and Bevacizumab. (2026). Radiology and Oncology, 60(1), 40-48. https://www.ojstest.computing.si/index.php/ro/article/view/4783